Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib...
Q1 2026
Mar 31, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Nov 7, 2025
Q2 2025
Aug 13, 2025